Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2 | Q05397 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4573186 | 0.76 | CHRNA7 (0.44) | PTK2PKMS1PR3S1PR1L3MBTL1 | |
| SCHEMBL27561961 | 0.75 | KMT2A (0.45) | PKMSMN1; SMN2L3MBTL1ALDH1A1POLB | |
| SCHEMBL9978328 | 0.72 | PTK2 (0.49) | PTK2SMN1; SMN2L3MBTL1ALDH1A1POLB | |
| SCHEMBL17420409 | 0.71 | L3MBTL1 (0.42) | PTK2SMN1; SMN2L3MBTL1POLBRAB9A | |
| SCHEMBL22758108 | 0.70 | PTK2 (0.42) | PTK2SMN1; SMN2L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL8247564 | 0.70 | FAAH (0.45) | PTK2SMN1; SMN2L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL2609326 | 0.69 | CCR9 (0.40) | PTK2SMN1; SMN2L3MBTL1ALDH1A1RAB9A | |
| SCHEMBL21631946 | 0.68 | SLC22A12 (0.38) | PKMSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL10831553 | 0.67 | NFE2L2 (0.44) | PTK2L3MBTL1ALDH1A1POLBMAPK1 | |
| SCHEMBL23535502 | 0.67 | HDAC1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1720865-B1 | 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2014-12-31 | — | — | EP | disclosed |
| US-7723363-B2 | 2-pyridinylethylcarboxamide derivatives and their use as fungicides | BAYER CROPSCIENCE SA (FR) | 2010-05-25 | — | — | US | disclosed |
| US-20070167491-A1 | 2-Pyridinylethylcarboxamide derivatives and their use as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-07-19 | — | — | US | disclosed |
| EP-1720865-A1 | 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | Bayer CropScience S.A. (FR) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005085238-A1 | 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2005-09-15 | — | — | WO | disclosed |
| EP-1574511-A1 | 2-Pyridinylethylcarboxamide derivatives and their use as fungicides | Bayer CropScience S.A. (FR) | 2005-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167491-A1 | 2-Pyridinylethylcarboxamide derivatives and their use as fungicides | CYP1A2, PNPO, PFAS | PTK2 4349/4885PKM 503/4885S1PR3 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.